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X-linked myotubular myopathy (XLMTM) is a rare congenital muscle disorder, 
caused by mutations in the MTM1 gene. Affected male infants present severe hy-
potonia, and generalized muscle weakness, and the disorder is most often compli-
cated by respiratory failure. Herein, we describe a family with 2 infants with 
XLMTM which was diagnosed by gene analysis and muscle biopsy. In both cases, 
histological findings of muscle showed severely hypoplastic muscle fibers with 
centrally placed nuclei. From the family gene analysis, the Arg486STOP mutation 
in the MTM1 gene was confirmed. 
Key Words:    X-linked recessive myotubular myopathy, Centronuclear myopathy, 
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INTRODUCTION
Centronuclear myopathy is a group of pathologically defined disorders that char-
acteristically have a high proportion of small myofibers with centrally placed nu-
clei.1 Spiro, et al.2 first described the term “myotubular myopathy” in 1967. A se-
vere form, called X-linked myotubular myopathy (XLMTM), is related to severe 
clinical features, such as hypotonia, generalized weakness, feeding difficulty, and 
respiratory distress requiring ventilator support. Patients with XLMTM show typi-
cal dysmorphic features characterized by severe hypotonia, generalized muscle 
weakness, and impaired maturation of muscle fibers, causing perinatal death of 
male infants.3 XLMTM pathogenesis is due to a mutation in the MTM1 gene on 
Xq28;4,5 it encodes a phosphoinositide lipid phosphatase, which is known as myo-
tubularin and appears to be important in muscle maintenance.6,7
To our best knowledge, this is the first report on an XLMTM family with 2 af-
fected infants diagnosed by muscle biopsy and gene analysis in Korea. A non-
sense mutation Arg486STOP was identified in exon 7 of the MTM1 gene in this 
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rule out myopathy. Results showed Arg486STOP genetic se-
quence and specific myotubular myopathy in muscle histolo-
gy. He was confirmed as XLMTM. Self respiration and 
spontaneous movement were not present after 55 days of life, 
therefore, his parents decided to withdraw care.
Patient 2 (IV 5)
The mother of the above case did not follow up at our hos-
pital in spite of our strong recommendation. Three years 
later, however, the mother visited us at the time of her third 
delivery. She had severe hydramnios similar to her previous 
pregnancy. A male baby was born at 36 weeks of gestation 
by cesarian section. He also showed severe hypotonia and 
respiration difficulty. A ventilator was used, and conserva-
tive care was given. The clinical courses were similar to 
those of patient 1. 
Muscle biopsy and gene analysis for the MTM1 gene 
were performed and confirmed the diagnosis of XLMTM. 
He was discharged and expired 28 days after birth. The en-
tire family, including the mother and healthy daughter, visit-
ed our genetics clinic to undergo gene analysis for the MTM1 
gene. The gene analysis revealed that the mother was a car-
rier of XLMTM, but the daughter was not (Fig. 1).
CASE REPORT
Patient 1 (IV 4)
A preterm male was born at 34 weeks of gestational age by 
normal spontaneous vaginal delivery and had a birth weight 
of 2.41 kg. Apgar score was 2 at 1 min, 6 at 5 min, and 7 at 
10 min. He had generalized muscle hypotonia that required 
ventilation and a lack of spontaneous movement. His mother, 
who underwent spontaneous abortion prior to this pregnancy, 
had a healthy daughter. During the antenatal period, severe 
hydramnios was detected. She had a family history of a cous-
in who was diagnosed with muscle disease and expired at the 
age of 3. Patient 1 was admitted to the Neonatal Intensive 
Care Unit after birth, and there were no signs of spontaneous 
movement or respiration. He showed a small, thin rib cage 
on the chest radiography. Lactate dehydrogenase (LDH) 
2286 was elevated only. Tandem mass spectrometry screen-
ings including amino acids, organic acids, fatty acids meta-
bolic disorders, brain ultrasonogram, and electromyography 
were non-specific. Although he was managed conservatively, 
the hypotonia was not improved. Therefore, we performed a 
chromosome analysis, gene analysis, and muscle biopsy to 
Fig. 1. Genetic analysis of the MTM1 mutation. Genetic sequences were examined in all family members. The father’s sequence is nor-
mal, but the mother shows that she is a carrier. Two case sequences show Arg486STOP, a nonsense mutation. Fortunately, the first fe-
male baby’s genes are normal.
Father
1st female baby
3rd male baby
Mother -carrier
2nd male babyTwo Infant Siblings with MTM1 Mutation
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to affected males.13,14 
To confirm XLMTM, a histological examination of mus-
cle specimen is necessary. The high proportion of centrally 
placed, relatively large nuclei on tinctorial stains are the 
typical findings of XLMTM.3 Gene analysis for MTM1 
gene mutations is necessary to confirm XLMTM, however, 
some patients with mild XLMTM are found to have no 
centrally located nuclei in muscle biopsies.15 
The gene MTM1, which is linked to XLMTM, is well es-
Muscle Biopsy
Histological findings of the muscle biopsy were consistent 
with centritubular (myotubular) myopathy. HE-staining 
showed central nuclei in very high proportions of the rela-
tively small myofibers. In addition, severely hypoplastic 
muscle fibers with centrally placed nuclei were observed 
(Fig. 2). 
Genetics
In view of the morphological findings, an analysis for the 
MTM1 gene was performed and Arg486STOP, a nonsense 
mutation, was detected (Fig. 1). 
Pedigree (Fig. 3)
This pedigree is based from family history. The son of 
mother's first cousin died from an unknown myopathy at 3 
years old. He had been bed rest with home ventilator till 
that time.
DISCUSSION
XLMTM is a rare disease that affects one out of 50,000 
males and is due to MTM1 mutations.6,8 This disease is 
caused by a maturational arrest of the fetal muscle during 
the myotubular stage of development from the 8th to 15th 
week of gestation. Compared to other congenital myopa-
thies, patients with XLMTM have a rather homogeneous 
clinical presentation. They are characterized by severe hy-
potonia, generalized muscle weakness, impaired maturation 
of muscle fibers, and dysmorphic features associated with 
weakness. Antepartum symptoms of XLMTM include poly-
hydramnios (the most common feature), poor fetal move-
ment, and fetal cardiac arrhythmias. A high percentage of 
these patients require mechanical ventilation from birth 
throughout the duration of life.9 Many patients show suck-
ing/swallowing impairments, ophthalmoplegia, facial 
weakness, and joint contractures. They are rarely able to 
walk and remain severely hypotonic.
About 50% of patients who survived for 1 year need 24-
hour ventilatory support, and approximately 75% of severe-
ly affected neonates die within the first few weeks or months 
of life due to respiratory insufficiency.8 The average life ex-
pectancy of XLMTM patients is 29 months, but a number 
of papers reported adult survivors of the disease.10-12 A fe-
male carrier of XLMTM is generally asymptomatic and 
slowly pregressive, and the mortality is not high compared 
Fig. 2. Histological findings of muscle biopsy. (A) Muscle biopsy from pa-
tient 1 (IV 4). The HE-stained slide demonstrates central by located nuclei 
in very high proportion of relatively small myofibers (×200). (B) Muscle bi-
opsy from patient 2 (IV 5). Centrally located nuclei are present (HE ×400).
A
B
Fig. 3. Pedigree of the two brothers. This family tree shows important pri-
mary genetic information of these 2 cases. Black, affected; white, unaffect-
ed; grey, probably affected by history; question mark, affectation stuatus 
unknown. 
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tablished.16 The MTM1 gene is located on the proximal seg-
ment of the long arm of X chromosome (Xq28),17 and it 
consists of 15 exons and has an encoding sequence of myo-
tubularin with a tyrosine phosphatase domain. The muta-
tions are widespread, and are found in exons 4, 12, 3, 8, 9, 
and 11. Truncating mutations are the most common point 
mutations of XLMTM associated with a severe and early 
lethal phenotype, while some missense mutations are the 
cause of relatively milder forms of XLMTM; such as auto-
somal dominant centronuclear myopathy (ADCNM) that 
present slowly in adults with a diffuse weakness and auto-
somal recessive centronuclear myopathy (ARCNM) that 
presents muscle weakness in infancy or early childhood. 
The mutation in our cases resulted from an Arg486STOP 
nonsense mutation, and the mother of the patients was re-
vealed to be the carrier of the mutation.
To our best knowledge, this is the first case of sibling in-
fants diagnosed with XLMTM by muscle biopsy and gene 
analysis. The descriptions of the two patients with severe 
XLMTM from the same mother provide an important les-
son for clinicians to evaluate infantile muscular disorder 
(whether it saves the baby’s life or not) and to consult with 
the mother about prenatal family planning and antenatal ge-
netic screening.18 Despite the fact that pedigree analysis 
(Fig. 3) provides the first sign of a de novo mutation, gene 
studies on the healthy daughter in the XLMTM family are 
necessary because she may be a carrier of the XLMTM 
mutation. This will greatly affect her future if she decides to 
have her own children.14
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